Kairos Pharma Ltd's ROI from its second quarter of 2026 to the second quarter of 2025 and 5 Year Period

Return on Investment, Quarterly Results, Trends, Rankings, Statistics

What is Kairos Pharma Ltd's ROI in the second quarter of 2026?
Kairos Pharma Ltd recorded a cumulative net loss of $-6 million during 12 months ending in the second quarter of 2026, resulting in a negative return on investment (ROI) of -98.77%.

Within the Healthcare sector 610 other companies had a higher return on investment. While return on investment, the total ranking has deteriorated compared to the first quarter of 2026 from 3312 to 4005.

Definition and Formula of Return on Investment

Select the Comparisons :

None ▼

Select the Ratio:

Return on Investment ROI▼

None ▼

Return on Investment ROI▼

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

Return On Investment	(Jun 30 2026) II. Quarter	(Mar 31 2026) I. Quarter	(Dec 31 2025) IV. Quarter	(Sep 30 2025) III. Quarter	(Jun 30 2025) II. Quarter
Y / Y Investment Change TTM	10.7 %	82.06 %	300.62 %	1180.37 %	-
Y / Y Net Income Change TTM	-	-	-	-	-
Investment (TTM) in Millions	4	5	6	8	6
Return On Investment (TTM)	-98.77 %	-92.26 %	-80.3 %	-47.48 %	-50.55 %
KAPA's Overall Ranking	# 4005	# 3312	# 3497	# 3179	# 2998
Seq. Investment Change TTM	-7.13 %	-6.7 %	6.12 %	20.4 %	52.73 %
Seq. Net Income Change TTM	-	-	-	-	-
Net Income (TTM) in Millions	-6	-6	-5	-3	-3

KAPA Company Profile >> Back to KAPA Roi Comparisons >> See Annual KAPA Return On Investment

Return On Investment KAPA's Ranking
Within:	No.
Industry	# 276
Sector	# 611
Overall	# 4005

Return On Investment Statistics
High	Average	Low
-47.48 %	-82.51 %	-125.69 %
(Sep 30 2025)		(Sep 30 2024)

Financial Statements
Kairos Pharma Ltd's II. Quarter Investments	$ 4 Millions	KAPA's Balance sheet
Kairos Pharma Ltd's II. Quarter Income	$ -1 Millions	Quarterly KAPA's Income Statement
KAPA's Income by Division		See KAPA's Income by Division

KAPA Annual Return On Investment	(Dec 31 2025) 2025	(Dec 31 2024) 2024
Total Investments in Millions	6	5	0	0	0
Y / Y Investment Growth	32.77 %	-	-	-	-
Net Income in Millions	-5	-3	0	0	0
Y / Y Net Income Growth	-	-	-	-	-
Annual Return On Investment	-85.9 %	-54.5 %	-	-	-

Annual Roi Comment

Definition and Formula of Return on Investment

Other ROI Ratios
Major Pharmaceutical Preparations Industry Roi Trends and Statistics
Healthcare Sector Return On Investment Statistics
Roi Trends for overall market
KAPA's Roi Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Return On Investment
Lowest Ranking Return On Investment
Subscribers only: Roi for KAPA's Competitors
Subscribers only: Roi for Kairos Pharma Ltd's Suppliers
Subscribers only: Return On Investment for KAPA's Customers

Other Ratios
KAPA's Roa	KAPA's Inventory Turnover Ratio	KAPA's Growth Rates	KAPA's Dividend Statistics
	KAPA's Profitability Ratios	KAPA's Asset Turnover Ratio	KAPA's Dividend Growth
KAPA's Roe	KAPA's Valuation Ratios	KAPA's Financial Strength Ratios	KAPA's Dividend Payout Ratio

Companies with similar Return On Investment at Jun 30 2026, within Healthcare Sector

ROI

Date modified: 2026-09-03T23:52:22+00:00

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.